An international board of cancer geneticists, molecular oncologists, and pathologists who steward peer review and scientific quality at JCGB.
The page lists the public board records for JCGB. Affiliations, research-interest terms and ORCID iDs are shown where available in the journal database.
No board members match your search or filter. Try a different term, or clear to see the full board.
Genomic experiment design and analysis using UCSC Genome Browser and Primer-BLAST. Genetic/Epigenetic Analysis: 2nd Generation Sequencing, Chromatin Immunoprecipitation (ChIP) seq.
Scientist, SinoScript LLC.
Ovarian cancer
Chair of Medical Oncology, Honorary Consultant in Medical Oncology, Edinburgh Cancer Research Centre, Western General Hospital.
Molecular pathology; cancer biomarker discovery; HPV-associated cervical carcinogenesis; ovarian and nasopharyngeal carcinoma proteomics; tissue microarray and immunohistochemistry.
Professor & Pathologist, Universiti Sains Malaysia, Minden, Pulau Pinang
RNA, Cancer Biology, Cell Culture, Gene Expression, DNA, Western Blot Analysis, Immunohistochemistry, Immunofluorescence, Electrophoresis
Assistant Staff Scientist, Oklahoma Medical Research Foundation, Oklahoma City, OK
Cancer, Epigenetics, Drug Design, Chemotherapeutic Drug Resistance, Biomarkers
Professor, Pasteur Institute of Iran, Tehran
cancer, miRNA, Gene Expression, RNA Isolation, Real-Time PCR.
Department of Medical Genetics School of Medicine, Mugla Sitki Kocman University.
HPV, MOLECUALR CANCER BIOLOGY; CANCER STEM CELL RESEARCH
Principal Investigation, Council of Science and Technology, Uttar Pradesh, Uttar Pradesh, Uttar Pradesh
Cancer Biology, Cancer Metabolism, Translational Research, Nutrition Study, Biotechnology and Biomedical Science.
Stanford University, Stanford, CA
Leukemia, Lymphoma ,MPD, Targeted cancer gene therapy, Cancer biology, Cancer stem cells
University of Massachusetts Medical School
PCR Cell Culture Gel Electrophoresis DNA Western Blot Analysis Gene Expression DNA Extraction Cloning SDS-PAGE Cancer Biology Flow Cytometry Immunofluorescence
Moffitt Cancer Center · Department of Immunology.
Cancer Biologist and Drug Discovery Expert
Oncology Drug Discovery, Research and Development, Bristol-Myers Squibb.
Colorectal cancer, pancreas, molecular pathology, precursor lesions
Deputy Medical Director, Laboratory Medicine Program, University Health Network,Toronto Professor of Pathology, University of Toronto.
Molecular Biology, Microbiology, Genetics
Dept. of Genetics, Univ. of Georgia.
melanoma, molecular biology, vitamin D, nuclear receptors
Professor and Chair, Nicolaus Copernicus University, Toruń
ANXA2 , FAK , tPA , S100A family tumor-related genes and other functions. Tumor Signal Transduction and Regulation. Tumor cells, tissue surface markers and molecular probes screening research. Targeted cancer-targeted nanotherapeutics.
The Lab of Tumor Molecular Cellular Biology Shaanxi Normal University
Potential clinical use of biomarkers of oxidative DNA damage and systems of reparation. Optimization of radiotherapy with radiobiology model.
Professor, Nicolaus Copernicus University Collegium Medicum, Bydgoszcz
Cancer Biology, Diagnostics and therapeutics
Professor, Birla Institute of Technology and Science - Hyderabad Campus, Hyderabad, Telangana
Cell stress, Aging, Senescence, DNA methylation, Biology of nucleus, Molecular cytogenetics.
Rzeszów University, Rzeszów
Cancer Genetics Tumorigenesis Cell Signalling
Post-doctoral student, Harvard Medical School, Boston, MA
Oncology Clinical Oncology Chemotherapy HER2 Malignant Tumors Cancer Therapy
Doctor of Medicine Consultant at Azienda Ospedaliera Santa Maria di Terni
Oral Cancer Orofacial Pain Craniomandibular Disorders Oral Medicine Oral, Head and Neck Cancer
Hamdard University
Biomarkers, Drug targets, Infectious diseases, cancers, viruses, proteomics, metabolomics
Purdue Univeristy
Some members do not have a public ORCID iD on record; no identifier is inferred when the database field is absent or suppressed. Editors recuse themselves from any manuscript in which they have a conflict of interest.
The editorial board is responsible for the scholarly integrity of everything JCGB publishes. Editorial decisions rest on scientific merit and are independent of fees, membership, or any paid service.
Editors and reviewers declare competing interests and recuse themselves from handling their own submissions or any work where a conflict exists; those manuscripts are managed independently. Payment of an article processing charge, membership, or use of any optional service confers no advantage in review or the likelihood of acceptance.
The editorial board provides scholarly governance and makes editorial decisions. Open Access Pub, the publisher, provides production, hosting, Crossref DOIs, and preservation infrastructure — it does not make acceptance decisions.
Researchers in cancer genetics and biomarkers who would like to be considered for a reviewer or editorial role are welcome to write to the editorial office with a CV and areas of expertise.